APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brain Imaging Modalities and Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Brain Imaging Modalities and Software Market Outlook and Growth Opportunities 2026

2 May 2026191 pages

Choose your research edition.

Industry ResearchBrain Imaging Modalities and Software Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Brain Imaging Modalities and Software Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Brain Imaging Modalities and Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brain Imaging Modalities and Software Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Brain Imaging Modalities and Software Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Brain Imaging Modalities and Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Brain Imaging Modalities and Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Brain Imaging Modalities and Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brain Imaging Modalities and Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Brain Imaging Modalities and Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Brain Imaging Modalities and Software market include Quantib, Brainomix, General Electric, Imaging Biometrics, United Imaging Healthcare Co, Siemens, Healthineers AG, Koninklijke Philips N.V. and Canon, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Brain Imaging Modalities and Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Brain Imaging Modalities and Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Brain Imaging Modalities and Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Brain Imaging Modalities and Software market.

Brain Imaging Modalities and Software Segment by Company

Quantib

Brainomix

General Electric

Imaging Biometrics

United Imaging Healthcare Co

Siemens

Healthineers AG

Koninklijke Philips N.V.

Canon

Vuno

Aspect Imaging

IXICO

QMENTA

I. Analysis

Fujifilm Holdings

Other Prominent Players

Brain Imaging Modalities and Software Segment by Type

Brain Imaging Modalities

Brain Analysis Software

Brain Imaging Modalities and Software Segment by Application

Adults

Pediatrics and Infants

Brain Imaging Modalities and Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Brain Imaging Modalities and Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Brain Imaging Modalities and Software key companies, revenue, market share, and recent developments.

3. To split the Brain Imaging Modalities and Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Brain Imaging Modalities and Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Brain Imaging Modalities and Software significant trends, drivers, influence factors in global and regions.

6. To analyze Brain Imaging Modalities and Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brain Imaging Modalities and Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brain Imaging Modalities and Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brain Imaging Modalities and Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Brain Imaging Modalities and Software industry.

Chapter 3: Detailed analysis of Brain Imaging Modalities and Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Brain Imaging Modalities and Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Brain Imaging Modalities and Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Brain Imaging Modalities and Software Industry Trends Table 2. Brain Imaging Modalities and Software Industry Drivers Table 3. Brain Imaging Modalities and Software Industry Opportunities and Challenges Table 4. Brain Imaging Modalities and Software Industry Restraints Table 5. Global Brain Imaging Modalities and Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Brain Imaging Modalities and Software Revenue Share by Company (2021-2026) Table 7. Global Brain Imaging Modalities and Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Brain Imaging Modalities and Software Key Company Manufacturing Base & Headquarters Table 9. Global Brain Imaging Modalities and Software Company, Product Type & Application Table 10. Global Brain Imaging Modalities and Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Brain Imaging Modalities and Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Brain Imaging Modalities Table 15. Significant Companies of Brain Analysis Software Table 16. Global Brain Imaging Modalities and Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Brain Imaging Modalities and Software Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Brain Imaging Modalities and Software Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Brain Imaging Modalities and Software Sales Value Share by Type (2021-2026) Table 20. Global Brain Imaging Modalities and Software Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Adults Table 22. Significant Companies of Pediatrics and Infants Table 23. Global Brain Imaging Modalities and Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Brain Imaging Modalities and Software Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Brain Imaging Modalities and Software Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Brain Imaging Modalities and Software Sales Value Share by Application (2021-2026) Table 27. Global Brain Imaging Modalities and Software Sales Value Share by Application (2027-2032) Table 28. Global Brain Imaging Modalities and Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Brain Imaging Modalities and Software Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Brain Imaging Modalities and Software Sales Value Share by Region (2021-2026) Table 31. Global Brain Imaging Modalities and Software Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Brain Imaging Modalities and Software Sales Value Share by Region (2027-2032) Table 33. Global Brain Imaging Modalities and Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Brain Imaging Modalities and Software Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Brain Imaging Modalities and Software Sales Value Market Share by Country (2021-2026) Table 36. Global Brain Imaging Modalities and Software Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Brain Imaging Modalities and Software Sales Value Market Share by Country (2027-2032) Table 38. Quantib Company Information Table 39. Quantib Business Overview Table 40. Quantib Brain Imaging Modalities and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Quantib Brain Imaging Modalities and Software Product Portfolio Table 42. Quantib Recent Development Table 43. Brainomix Company Information Table 44. Brainomix Business Overview Table 45. Brainomix Brain Imaging Modalities and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Brainomix Brain Imaging Modalities and Software Product Portfolio Table 47. Brainomix Recent Development Table 48. General Electric Company Information Table 49. General Electric Business Overview Table 50. General Electric Brain Imaging Modalities and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. General Electric Brain Imaging Modalities and Software Product Portfolio Table 52. General Electric Recent Development Table 53. Imaging Biometrics Company Information Table 54. Imaging Biometrics Business Overview Table 55. Imaging Biometrics Brain Imaging Modalities and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Imaging Biometrics Brain Imaging Modalities and Software Product Portfolio Table 57. Imaging Biometrics Recent Development Table 58. United Imaging Healthcare Co Company Information Table 59. United Imaging Healthcare Co Business Overview Table 60. United Imaging Healthcare Co Brain Imaging Modalities and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. United Imaging Healthcare Co Brain Imaging Modalities and Software Product Portfolio Table 62. United Imaging Healthcare Co Recent Development Table 63. Siemens Company Information Table 64. Siemens Business Overview Table 65. Siemens Brain Imaging Modalities and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Siemens Brain Imaging Modalities and Software Product Portfolio Table 67. Siemens Recent Development Table 68. Healthineers AG Company Information Table 69. Healthineers AG Business Overview Table 70. Healthineers AG Brain Imaging Modalities and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Healthineers AG Brain Imaging Modalities and Software Product Portfolio Table 72. Healthineers AG Recent Development Table 73. Koninklijke Philips N.V. Company Information Table 74. Koninklijke Philips N.V. Business Overview Table 75. Koninklijke Philips N.V. Brain Imaging Modalities and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Koninklijke Philips N.V. Brain Imaging Modalities and Software Product Portfolio Table 77. Koninklijke Philips N.V. Recent Development Table 78. Canon Company Information Table 79. Canon Business Overview Table 80. Canon Brain Imaging Modalities and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Canon Brain Imaging Modalities and Software Product Portfolio Table 82. Canon Recent Development Table 83. Vuno Company Information Table 84. Vuno Business Overview Table 85. Vuno Brain Imaging Modalities and Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Vuno Brain Imaging Modalities and Software Product Portfolio Table 87. Vuno Recent Development Table 88. Aspect Imaging Company Information Table 89. Aspect Imaging Business Overview Table 90. Aspect Imaging Brain Imaging Modalities and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Aspect Imaging Brain Imaging Modalities and Software Product Portfolio Table 92. Aspect Imaging Recent Development Table 93. IXICO Company Information Table 94. IXICO Business Overview Table 95. IXICO Brain Imaging Modalities and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. IXICO Brain Imaging Modalities and Software Product Portfolio Table 97. IXICO Recent Development Table 98. QMENTA Company Information Table 99. QMENTA Business Overview Table 100. QMENTA Brain Imaging Modalities and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. QMENTA Brain Imaging Modalities and Software Product Portfolio Table 102. QMENTA Recent Development Table 103. I. Analysis Company Information Table 104. I. Analysis Business Overview Table 105. I. Analysis Brain Imaging Modalities and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. I. Analysis Brain Imaging Modalities and Software Product Portfolio Table 107. I. Analysis Recent Development Table 108. Fujifilm Holdings Company Information Table 109. Fujifilm Holdings Business Overview Table 110. Fujifilm Holdings Brain Imaging Modalities and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Fujifilm Holdings Brain Imaging Modalities and Software Product Portfolio Table 112. Fujifilm Holdings Recent Development Table 113. Other Prominent Players Company Information Table 114. Other Prominent Players Business Overview Table 115. Other Prominent Players Brain Imaging Modalities and Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Other Prominent Players Brain Imaging Modalities and Software Product Portfolio Table 117. Other Prominent Players Recent Development Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Brain Imaging Modalities and Software Product Image Figure 2. Global Brain Imaging Modalities and Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brain Imaging Modalities and Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Brain Imaging Modalities and Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Brain Imaging Modalities Image Figure 8. Brain Analysis Software Image Figure 9. Global Brain Imaging Modalities and Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Brain Imaging Modalities and Software Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Brain Imaging Modalities and Software Sales Value Share by Type (2021-2032) Figure 12. Adults Image Figure 13. Pediatrics and Infants Image Figure 14. Global Brain Imaging Modalities and Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Brain Imaging Modalities and Software Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Brain Imaging Modalities and Software Sales Value Share by Application (2021-2032) Figure 17. Global Brain Imaging Modalities and Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Brain Imaging Modalities and Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Brain Imaging Modalities and Software Sales Value (2021-2032) & (US$ Million) Figure 20. North America Brain Imaging Modalities and Software Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Brain Imaging Modalities and Software Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Brain Imaging Modalities and Software Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Brain Imaging Modalities and Software Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Brain Imaging Modalities and Software Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Brain Imaging Modalities and Software Sales Value (2021-2032) & (US$ Million) Figure 26. South America Brain Imaging Modalities and Software Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Brain Imaging Modalities and Software Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Brain Imaging Modalities and Software Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Brain Imaging Modalities
  • Brain Analysis Software
Applications
  • Adults
  • Pediatrics and Infants
Companies covered
  • Quantib
  • Brainomix
  • General Electric
  • Imaging Biometrics
  • United Imaging Healthcare Co
  • Siemens
  • Healthineers AG
  • Koninklijke Philips N.V.
  • Canon
  • Vuno
  • Aspect Imaging
  • IXICO
  • QMENTA
  • I. Analysis
  • Fujifilm Holdings
  • Other Prominent Players

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Brain Imaging Modalities and Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Brain Imaging Modalities and Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Brain Imaging Modalities and Software Market Dynamics
  1. 2.1 Brain Imaging Modalities and Software Industry Trends
  2. 2.2 Brain Imaging Modalities and Software Industry Drivers
  3. 2.3 Brain Imaging Modalities and Software Industry Opportunities and Challenges
  4. 2.4 Brain Imaging Modalities and Software Industry Restraints
3 Brain Imaging Modalities and Software Market by Company
  1. 3.1 Global Brain Imaging Modalities and Software Company Revenue Ranking in 2025
  2. 3.2 Global Brain Imaging Modalities and Software Revenue by Company (2021-2026)
  3. 3.3 Global Brain Imaging Modalities and Software Company Ranking (2024-2026)
  4. 3.4 Global Brain Imaging Modalities and Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Brain Imaging Modalities and Software Company Product Type and Application
  6. 3.6 Global Brain Imaging Modalities and Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Brain Imaging Modalities and Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Brain Imaging Modalities and Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Brain Imaging Modalities and Software Market by Type
  1. 4.1 Brain Imaging Modalities and Software Type Introduction
  2. 4.1.1 Brain Imaging Modalities
  3. 4.1.2 Brain Analysis Software
  4. 4.2 Global Brain Imaging Modalities and Software Sales Value by Type
  5. 4.2.1 Global Brain Imaging Modalities and Software Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Brain Imaging Modalities and Software Sales Value by Type (2021-2032)
  7. 4.2.3 Global Brain Imaging Modalities and Software Sales Value Share by Type (2021-2032)
5 Brain Imaging Modalities and Software Market by Application
  1. 5.1 Brain Imaging Modalities and Software Application Introduction
  2. 5.1.1 Adults
  3. 5.1.2 Pediatrics and Infants
  4. 5.2 Global Brain Imaging Modalities and Software Sales Value by Application
  5. 5.2.1 Global Brain Imaging Modalities and Software Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Brain Imaging Modalities and Software Sales Value by Application (2021-2032)
  7. 5.2.3 Global Brain Imaging Modalities and Software Sales Value Share by Application (2021-2032)
6 Brain Imaging Modalities and Software Regional Value Analysis
  1. 6.1 Global Brain Imaging Modalities and Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Brain Imaging Modalities and Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Brain Imaging Modalities and Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Brain Imaging Modalities and Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Brain Imaging Modalities and Software Sales Value (2021-2032)
  7. 6.3.2 North America Brain Imaging Modalities and Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Brain Imaging Modalities and Software Sales Value (2021-2032)
  10. 6.4.2 Europe Brain Imaging Modalities and Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Brain Imaging Modalities and Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Brain Imaging Modalities and Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Brain Imaging Modalities and Software Sales Value (2021-2032)
  16. 6.6.2 South America Brain Imaging Modalities and Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Brain Imaging Modalities and Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Brain Imaging Modalities and Software Sales Value Share by Country, 2025 VS 2032
7 Brain Imaging Modalities and Software Country-level Value Analysis
  1. 7.1 Global Brain Imaging Modalities and Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Brain Imaging Modalities and Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Brain Imaging Modalities and Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Brain Imaging Modalities and Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Brain Imaging Modalities and Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Brain Imaging Modalities and Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Brain Imaging Modalities and Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Quantib
  2. 8.1.1 Quantib Company Information
  3. 8.1.2 Quantib Business Overview
  4. 8.1.3 Quantib Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Quantib Brain Imaging Modalities and Software Product Portfolio
  6. 8.1.5 Quantib Recent Developments
  7. 8.2 Brainomix
  8. 8.2.1 Brainomix Company Information
  9. 8.2.2 Brainomix Business Overview
  10. 8.2.3 Brainomix Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Brainomix Brain Imaging Modalities and Software Product Portfolio
  12. 8.2.5 Brainomix Recent Developments
  13. 8.3 General Electric
  14. 8.3.1 General Electric Company Information
  15. 8.3.2 General Electric Business Overview
  16. 8.3.3 General Electric Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 General Electric Brain Imaging Modalities and Software Product Portfolio
  18. 8.3.5 General Electric Recent Developments
  19. 8.4 Imaging Biometrics
  20. 8.4.1 Imaging Biometrics Company Information
  21. 8.4.2 Imaging Biometrics Business Overview
  22. 8.4.3 Imaging Biometrics Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Imaging Biometrics Brain Imaging Modalities and Software Product Portfolio
  24. 8.4.5 Imaging Biometrics Recent Developments
  25. 8.5 United Imaging Healthcare Co
  26. 8.5.1 United Imaging Healthcare Co Company Information
  27. 8.5.2 United Imaging Healthcare Co Business Overview
  28. 8.5.3 United Imaging Healthcare Co Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 United Imaging Healthcare Co Brain Imaging Modalities and Software Product Portfolio
  30. 8.5.5 United Imaging Healthcare Co Recent Developments
  31. 8.6 Siemens
  32. 8.6.1 Siemens Company Information
  33. 8.6.2 Siemens Business Overview
  34. 8.6.3 Siemens Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Siemens Brain Imaging Modalities and Software Product Portfolio
  36. 8.6.5 Siemens Recent Developments
  37. 8.7 Healthineers AG
  38. 8.7.1 Healthineers AG Company Information
  39. 8.7.2 Healthineers AG Business Overview
  40. 8.7.3 Healthineers AG Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Healthineers AG Brain Imaging Modalities and Software Product Portfolio
  42. 8.7.5 Healthineers AG Recent Developments
  43. 8.8 Koninklijke Philips N.V.
  44. 8.8.1 Koninklijke Philips N.V. Company Information
  45. 8.8.2 Koninklijke Philips N.V. Business Overview
  46. 8.8.3 Koninklijke Philips N.V. Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Koninklijke Philips N.V. Brain Imaging Modalities and Software Product Portfolio
  48. 8.8.5 Koninklijke Philips N.V. Recent Developments
  49. 8.9 Canon
  50. 8.9.1 Canon Company Information
  51. 8.9.2 Canon Business Overview
  52. 8.9.3 Canon Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Canon Brain Imaging Modalities and Software Product Portfolio
  54. 8.9.5 Canon Recent Developments
  55. 8.10 Vuno
  56. 8.10.1 Vuno Company Information
  57. 8.10.2 Vuno Business Overview
  58. 8.10.3 Vuno Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Vuno Brain Imaging Modalities and Software Product Portfolio
  60. 8.10.5 Vuno Recent Developments
  61. 8.11 Aspect Imaging
  62. 8.11.1 Aspect Imaging Company Information
  63. 8.11.2 Aspect Imaging Business Overview
  64. 8.11.3 Aspect Imaging Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Aspect Imaging Brain Imaging Modalities and Software Product Portfolio
  66. 8.11.5 Aspect Imaging Recent Developments
  67. 8.12 IXICO
  68. 8.12.1 IXICO Company Information
  69. 8.12.2 IXICO Business Overview
  70. 8.12.3 IXICO Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 IXICO Brain Imaging Modalities and Software Product Portfolio
  72. 8.12.5 IXICO Recent Developments
  73. 8.13 QMENTA
  74. 8.13.1 QMENTA Company Information
  75. 8.13.2 QMENTA Business Overview
  76. 8.13.3 QMENTA Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 QMENTA Brain Imaging Modalities and Software Product Portfolio
  78. 8.13.5 QMENTA Recent Developments
  79. 8.14 I. Analysis
  80. 8.14.1 I. Analysis Company Information
  81. 8.14.2 I. Analysis Business Overview
  82. 8.14.3 I. Analysis Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 I. Analysis Brain Imaging Modalities and Software Product Portfolio
  84. 8.14.5 I. Analysis Recent Developments
  85. 8.15 Fujifilm Holdings
  86. 8.15.1 Fujifilm Holdings Company Information
  87. 8.15.2 Fujifilm Holdings Business Overview
  88. 8.15.3 Fujifilm Holdings Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Fujifilm Holdings Brain Imaging Modalities and Software Product Portfolio
  90. 8.15.5 Fujifilm Holdings Recent Developments
  91. 8.16 Other Prominent Players
  92. 8.16.1 Other Prominent Players Company Information
  93. 8.16.2 Other Prominent Players Business Overview
  94. 8.16.3 Other Prominent Players Brain Imaging Modalities and Software Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Other Prominent Players Brain Imaging Modalities and Software Product Portfolio
  96. 8.16.5 Other Prominent Players Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst